Ted Okon Discusses the Impact of PBM Involvement in 340B
The involvement of pharmacy benefit managers (PBMs) in 340B is the “colliding of 2 worlds,” said Ted Okon, MBA, executive director, Community Oncology Alliance (COA).
Congress eyes faster Medicare Advantage prior authorizations
Providers may soon find it easier to get prior authorization decisions from Medicare Advantage plans under legislation moving through Congress.
HHS declares public health emergency over monkeypox
The Department of Health and Human Services Secretary Xavier Becerra declared a public health emergency to combat the growing monkeypox outbreak as U.S. cases surge past 6,000.
SchumerCare and Cancer Patients
Much of the damage from the Schumer-Manchin drug pricing deal won’t become visible for years. But people who understand the industry can already foresee it, and one example is fewer treatment options for desperately .....
To save children with cancer, doctors turn to new weapons
When Michelle Monje was a medical student 20 years ago, she saw her first case of diffuse intrinsic pontine glioma, a childhood brain cancer that is almost always fatal within a year.
AHA asks federal court to closely scrutinize how CMS repays hospitals over 340B payment cuts
Hospitals that weren't affected by cuts to the 340B drug discount program shouldn’t be required to repay any of those funds now that the Supreme Court ruled such cuts were unlawful, a key industry .....
CMS Announces Enhancing Oncology Model Successor to Oncology Care Model
Federal lawmakers are at the plate again, ready to take a swing at prescription drug prices.
Hematology-Oncology Associates of Central New York Lends Its Voice to Growing Chorus of Oncologists Opposing New York’s New Definition of the “Oncologic Protocol”
As previously reported, Frier Levitt filed suit against the New York Department of Health and the New York State Department of Education on behalf of an independent New York oncology practice in an effort .....
U.S. Prescription Drug Market Often Isn’t Competitive: Case Of Biosimilars
Federal lawmakers are at the plate again, ready to take a swing at prescription drug prices.
Seventh Circuit Resurrects Physician’s Antitrust Challenge to Loss of Medical Staff Privileges
Although many attempts by physicians to challenge hospital medical staff privileges terminations on antitrust grounds have fallen flat over the years, often because of perceived failures by the plaintiff to allege an appropriate geographic .....
Get Involved. Join COPA for FREE Today!
Exclusively available to members of community oncology practices with in-office dispensing and retail pharmacies. Representatives from every level of the pharmacy and practice teams are invited to participate. By sharing insights, COPA offers a forum for the advancement of integral cancer treatment dispensing clinics. Start strengthening your practice pharmacy operations today!
